Category Archives: CLSA Home

CLSA Hosts Meet & Greet with Congressman-elect Mike Levin (CA-49)

By Jenny Nieto Nov. 16, 2018 On Nov. 16, CLSA was honored to convene a Meet & Greet with Representative-elect Mike Levin (D-San Juan Capistrano/San Diego) at our Washington, DC office. As you may know, attorney Mike Levin was elected Nov. 6  to serve as the new U.S. Representative for California’s 49th Congressional District.  He … Continue reading CLSA Hosts Meet & Greet with Congressman-elect Mike Levin (CA-49)

Trump Administration Advancing Proposals Outlined in “Blueprint” to Address Prescription Drug Pricing

Addressing drug pricing and improving healthcare access and affordability remains a salient topic on Capitol Hill, in the Trump Administration, with industry and the public. Over the summer, the Administration released its American Patients First blueprint, and over the past several weeks, the Administration has announced draft or final proposals intended to lower drug prices and increase access to affordable prescription drugs.

What’s Next for the Remainder of 2018? Federal Legislative Outlook on Government Funding, Medical Device Tax and PAHPA Reauthorization

Both the House and Senate have adjourned until after the midterm elections. While the outcome of the elections will determine whether the Democrats win a majority in either the House or the Senate (or both), or if the Republicans maintain control of one or both chambers in the 116th Congress, both the House and Senate will return to Washington, D.C. in late November and early December (approximately 16-20 legislative days) to finish legislative work prior to the end of the year and the 115th Congress.

Possible new Life Sciences Hub in Los Angeles

California Life Sciences Association (CLSA) welcomes the Los Angeles World Airports (LAWA) vision to begin the RFQ/RFP process for the development of a biomedical complex on the LAWA northside area site. This concept will greatly bolster California’s ability to keep up with the needs of the sector and further provide economic development opportunities for innovative life science companies.